A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age

The trivalent inactivated influenza vaccine Fluarix™ is licensed in the US for adults and children from 3 years old. This randomized observer-blind study (NCT00764790) evaluated Fluarix™ at two doses; 0.25 ml (Flu-25) and 0.5 ml (Flu-50) in children aged 6–35 months. The primary objective was to dem...

Descripción completa

Detalles Bibliográficos
Autores principales: Pavia-Ruz, Noris, Angel Rodriguez Weber, Miguel, Lau, Yu-Lung, Nelson, E Anthony S, Kerdpanich, Angkool, Huang, Li-Min, Silas, Peter, Qaqundah, Paul, Blatter, Mark, Jeanfreau, Robert, Lei, Paul, Jain, Varsha, El Idrissi, Mohamed, Feng, Yang, Innis, Bruce, Peeters, Mathieu, Devaster, Jeanne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906365/
https://www.ncbi.nlm.nih.gov/pubmed/23782962
http://dx.doi.org/10.4161/hv.25363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906365/
https://www.ncbi.nlm.nih.gov/pubmed/23782962
http://dx.doi.org/10.4161/hv.25363

Ejemplares similares